AI-generated summary
This split-face study compared a 1064 nm Q-switched Nd:YAG laser alone with the same laser plus 1550 nm fractional photothermolysis for facial melasma in 26 Asian patients. The authors report that subjective improvement and physician-rated scores were virtually identical on both sides, and that no serious side effects occurred. They conclude that their findings do not support a substantial added benefit of the fractional treatment.
- Participants
- 26
- Who or what was studied
- Patients with facial melasma in Asian skin
- Wavelengths
- 1064, 1550 nm
- Limits stated in the abstract
- The abstract does not state a control group beyond the split-face design, and the sample size is small at 26 patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1550 nm, 1064 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Fluence, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.